본문 바로가기
KERD
논문KCI 등재

악성 림프종 치료에 대한 한의 임상진료지침

Clinical Practice Guidelines of Korean Medicine for Malignant Lymphoma

2

조회

0

다운로드

4

인용

0

참고문헌

키워드

주제분류한의학

초록

Objective: The purpose of this study was to present the clinical practice guideline of Korean medicine for malignant lymphoma. Background: Malignant lymphoma is the tenth most common cancer in Korea. The two main types of lymphoma are Hodgkin’s disease and non-Hodgkin’s lymphoma. Non-Hodgkin’s lymphomas are more common, comprising nearly 95 percent of all lymphomas. In China, the traditional Chinese medicine clinical guidelines for malignant lymphoma were published in 2014. Therefore, there is growing need for a clinical practice guideline in Korea, which has not thus far existed. This clinical practice guideline was created by reviewing the Chinese clinical practice guideline and Korean clinical reports. This study will be helpful in understanding malignant lymphoma and in understanding its treatment in Korean medicine. Conclusion: Further clinical research on malignant lymphoma is needed to develop a more advanced clinical guideline.

Abstract

Objective: The purpose of this study was to present the clinical practice guideline of Korean medicine for malignant lymphoma. Background: Malignant lymphoma is the tenth most common cancer in Korea. The two main types of lymphoma are Hodgkin’s disease and non-Hodgkin’s lymphoma. Non-Hodgkin’s lymphomas are more common, comprising nearly 95 percent of all lymphomas. In China, the traditional Chinese medicine clinical guidelines for malignant lymphoma were published in 2014. Therefore, there is growing need for a clinical practice guideline in Korea, which has not thus far existed. This clinical practice guideline was created by reviewing the Chinese clinical practice guideline and Korean clinical reports. This study will be helpful in understanding malignant lymphoma and in understanding its treatment in Korean medicine. Conclusion: Further clinical research on malignant lymphoma is needed to develop a more advanced clinical guideline.

참고문헌 (19)

  1. Annual report of cancer statistics in Korea in 2013, "Minister of Health and Welfare", ~ (2015)
  2. 엄석기, "漢代까지의 종기·혹·덩어리에 對한 疾病認識 考察", 대한한의학원전학회지, 21(2), pp.39~48 (2008), 대한한의학원전학회
  3. Chen XY, "Combination therapy of malignant lymphoma" (2008), Chemical Industry Press medical publishing branch
  4. Field MJ, "Clinical practice guidelines:directions for a new program" (1990), National Academy Press
  5. Lin HS, "Clinical practice guideline of Traditional Chinese Medicine for Cancer", pp.540~566 (2014), People's Health Publishing House
  6. Korean Society of Hematology, "Hematology", pp.368~401 (2011), Panmuneducation
  7. Chen XY, "Exploration to Traditional Chinese Medicine syndrome and common symptom of malignant lymphoma(stone gangrene)", Beijing Traditional Chinese Medicine, 31(10), pp.727~729 (2012)
  8. Zhao ZZ, "Exploration to relationship between syndrome and prognosis of malignant lymphoma", Beijing Traditional Chinese Medicine, 30(11), pp.807~809 (2011)
  9. 차희정, "호지킨 림프종의 병리학적 특징과 감별진단", 대한내과학회지, 81(5), pp.543~553 (2011), 대한내과학회
  10. Elias C, "The WHO classification of lymphoid neoplasms and beyound: evolving concepts and practical applications", Blood, 117(19), pp.5019~5031 (2011)
  11. "A predictive model for aggressive non-Hodgkin lymphoma. The international Non-Hodgkin lymphoma prognostic factor project", N Engl J Med, 329, pp.987~994 (1993)
  12. "Hodgkin lymphoma 2015" (2015)[URL]
  13. 김진만, "WHO Classification of Malignant Lymphomas in Korea: Report of the Third Nationwide Study", Journal of Pathology and Translational Medicine, 45(3), pp.254~260 (2011), 대한병리학회
  14. "Non-Hodgkin lymphoma 2015" (2015)[URL]
  15. Coiffier B, "Long term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patient: a study by the Groupe d’Etudes des Lymphomes de L’Adult", Blood, 116, pp.2040~2045 (2010)
  16. Kim YS, "Herb medications on angiocentric T-cell lymphoma with intra-abdominal metastasis:a case report", J of Kor Oriental Oncology, 10(1), pp.93~98 (2005)
  17. 한성수, "항암단을 투여 받은 림프절 외 변연부 B세포 림프종 환자에 대한 증례보고", 대한한방내과학회지, 29(3), pp.810~818 (2008), 대한한방내과학회
  18. 김인수, "미만성 거대 B세포 림프종 환자의 한의약치료 증례보고", 동의생리병리학회지, 28(2), pp.233~237 (2014), 한의병리학회
  19. 최성헌, "吳茱萸附子理中湯 및 祛風散으로 발열, 통증, 전신활동도, 두통 호전을 보인 소음인 말초성 T세포 림프종 환자 1례", 사상체질의학회지, 24(4), pp.100~108 (2012), 사상체질의학회[DOI]

관련 논문AI추천

이 간행물의 다른 논문 (12건)